Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report

Chen, YB; Paz-Ares, L; Reinmuth, N; Garassino, MC; Statsenko, G; Hochmair, MJ; Özgüroglu, M; Verderame, F; Havel, L; Losonczy, G; Conev, N; Hotta, K; Ji, JH; Spencer, S; Dalvi, T; Jiang, HY; Goldman, JW

Chen, YB (通讯作者),Canc & Hematol Ctr Western Michigan PC, Lemmen Holton Canc Pavil, 145 Michigan St NE,Suite 3100, Grand Rapids, MI 49503 USA.

JTO CLINICAL AND RESEARCH REPORTS, 2023; 3 (6):

Abstract

Introduction: In the phase 3 study involving the use of durvalumab with or without tremelimumab in combination with platinum-based chemotherapy in unt......

Full Text Link